Mozart Therapeutics logo

Mozart Therapeutics jobs and careers

Seattle, WA, United States

About Mozart Therapeutics

Mozart Therapeutics is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases. The company is using a novel regulatory CD8 T cell network to create disease-modifying CD8 Treg modulators for a variety of autoimmune diseases. Mozart is developing a pipeline of first-in-class 'CD8Treg modulators with the goal of restoring long-term immune balance and preventing the progressive damage caused by an autoreactive and pathogenic immune response.

Founded in 2020 by Mark Davis.

Founded
2020
Employees
1 to 10
Total funding
$80M
Headquarters
Seattle

Leadership

The top of Mozart Therapeutics's org chart, with how many people report into each leader.

KFPhoto of Katie Fanning

Katie Fanning

President & CEO

19 reports

KSPhoto of Kristine Swiderek

Kristine Swiderek

Chief Scientific Officer

11 reports

JCPhoto of Jason Chien

Jason Chien

Chief Medical Officer

2 reports

RHPhoto of Russ Hawkinson

Russ Hawkinson

Chief Financial Officer

1 report

KMPhoto of Kristi Manjarrez

Kristi Manjarrez

Senior Vice President, Portfolio Strategy And Program Management

JMPhoto of Jennifer More

Jennifer More

Sr. Director, Human Resources

Board

JMPhoto of Jasmina Marjanovic

Jasmina Marjanovic

Director

MPPhoto of Marie-Claire Peakman

Marie-Claire Peakman

Member Board of Directors

HRPhoto of Henrijette Richter

Henrijette Richter

Director

TDPhoto of Tom Daniel

Tom Daniel

Director

FPPhoto of Fabio Pucci

Fabio Pucci

Member Board of Directors

MDPhoto of Mark M. Davis

Mark M. Davis

Scientific Advisory Board Member